Skip to main content

Day: February 24, 2021

The Future is Now: AMC Networks and Omnicom Media Group Complete First National Addressable Campaign

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) — AMC Networks and Omnicom Media Group (OMG) today announced the successful completion of two first-to-market national linear addressable campaigns, a significant and long-awaited step to unleashing the potential of addressable advertising on television at scale. The November and December campaigns featuring Volkswagen and another major advertiser utilized AMC Networks’ On Addressability partnership with Canoe Ventures, with spots running across the nation on Comcast and Charter cable systems, reaching nearly 25 million homes across the U.S. Future executions will include Cox cable systems as well.“This is a moment television networks, distributors and our advertising partners have been anticipating and working toward for many years, unleashing the power and potential of addressable advertising...

Continue reading

AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Ampligen to Treat Pancreatic Cancer

OCALA, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that its subsidiary, NV Hemispherx Biopharma Europe, has received formal notification from the European Commission (EC) approving the company’s Orphan Medicinal Product Application for Ampligen as a treatment for pancreatic cancer.Medications that have been designated as Orphan products by the European Medicines Agency (EMA), once commercially approved in the European Union (EU), receive benefits including up to ten years of protection from market competition from similar medicines with similar active component and indication for use that are not shown to be clinically superior.AIM announced earlier this month that the Committee for Orphan Medicinal Products of the EMA had recommended that Ampligen receive the designation for pancreatic...

Continue reading

Prime Mining Named to TSX Venture Exchange “Venture 50”

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime” or the “Company”) (TSX-V: PRYM, OTCQB: PRMNF, Frankfurt: A2PRDW) is pleased to announce that it has been named to the 2021 TSX Venture 50, an annual ranking of top performing listed companies from five industry sectors including, Mining, Oil & Gas, Clean Technology and Life Sciences, Diversified Industries and Technology.The 2021 Venture 50 top performers were selected based on year-over-year performance across three equally weighted criteria: market capitalization growth, share price appreciation, and trading volume for the year ended December 31, 2020. Prime Mining Interview with CEO Daniel Kunz“We are extremely honored to be recognized and selected by the TSX Venture Exchange within the top 10 of Mining Companies,” stated Daniel Kunz,...

Continue reading

BOQI International Medical Enters into An Amendment to the Securities Purchase Agreement to Increase the Principal Amount of Senior Convertible Promissory Notes to Be Purchased by Two Institutional Investors

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) — BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces that it has entered into an amendment to the Securities Purchase Agreement with two institutional investors (the “Investors”) that was previously announced on May 19, 2020. The Amendment increases the principal amount of senior convertible promissory notes to be purchased by the Investors.Pursuant to the amendment, the aggregate principal amount of senior convertible promissory notes of the Company that may be purchased by the Investors was increased to $5,400,000 from $2,100,000 (the “Base Amount”) (the “Additional Notes”). The purchase price for the $5,400,000 principal amount of the notes will be $4,500,000 in cash and will not bear interest except upon the occurrence of an event of default. In addition,...

Continue reading

American Lithium Named to TSX Venture Exchange “Venture 50”

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V: LI, OTCQB: LIACF, Frankfurt: 5LA1) is pleased to announce that it has been named to the 2021 TSX Venture 50, an annual ranking of top performing listed companies on the TSX Venture Exchange.The 2021 TSX Venture 50 is an annual ranking of the top performing listed companies from five industry sectors: Clean Technology and Life Sciences, Diversified Industries, Energy, Mining, and Technology. The selection is based on year-over-year performance across three equally weighted criteria: market capitalization growth, share price appreciation and trading volume for the year ended December 31, 2020.American Lithium Interview with Founder Andrew Bowering“We are very pleased to be recognized in the 2021 TSX Venture...

Continue reading

Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Complete Vaccine™ Development Program

Ii-Key-SARS-CoV-2 vaccine generates vaccine-specific antibodies and T cell responses in a transgenic mouse modelThe Ii-Key vaccine elicits both CD4+ T Helper cell (Th1) and CD8+ responses that are necessary for long-term immune memoryInitiated discussions with a major research institution on licensing therapeutic antibodies against SARS-CoV-2MIRAMAR, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT)  (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the company has completed the mouse immunogenicity study with transgenic mice that have been genetically engineered with a gene from the human immune system called the DR4 human leukocyte antigen (HLA) allele, which is one of hundreds of alleles in the human immune system. HLAs are proteins – or markers -found...

Continue reading

Loncor Continues to Define Four Extensive Mineralized Trends to Southeast of Key Adumbi Deposit

TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce that recent soil geochemical results have outlined four significant, undrilled mineralised trends at its 84.68%-owned Imbo Project. The focus of greenfields exploration by Loncor at Imbo East, along trend to the southeast from the 2.5 million ounce Adumbi, Kitenge and Manzako deposits (inferred mineral resources of 30.65 million tonnes grading 2.54 g/t Au) previously delineated in the northwest of the 122 square kilometre project area. Core drilling is currently being undertaken at Adumbi to increase this resource base.Analytical results have now been received for all soil samples from the completed 5.4 kilometre by 2.3 kilometre...

Continue reading

Sulliden Mining Capital Inc. (SMC: TSX) Announces 52.4 m at 1.14 g/t Gold Equivalent Adjacent to Eldorado’s Triangle Mine on Its 100% Owned East-Sullivan Formerly Producing Property

Highlights include:52.4 m at 0.45% Cu and 0.44g/t Au, or 1.14 g/t Au EQ20.2 m at 0.66% Cu and 0.40 g/t Au, or 1.43 g/t Au EQ9.0 m at 0.95% Cu and 0.14 g/t Au, or 1.62 g/t Au EQTORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Sulliden Mining Capital Inc. (“Sulliden” or the “Company”) (TSX: SMC) is pleased to announce the results of its 2019 and 2020 drilling campaigns on its 100% owned East-Sullivan property (the “Property”). The Property is located in the heart of one of the most prolific gold and copper greenstone belts in the world, which is within the historical mining camp of Val-d’Or, Quebec, Canada. The Property is adjacent to and less than 2km away from Eldorado Gold Corp.’s Lamaque mining operation (Triangle zone, Figure 1). Note that Eldorado has entered into a definitive arrangement agreement pursuant to which it is expected...

Continue reading

Unaudited financial results of “Latvijas Gāze” group for 2020

The year 2020 has been challenging for both the world as a whole and for the energy industry in particular. Relatively mild air temperatures, strict restrictions due to the spread of the coronavirus, and low level of natural gas prices were the main factors shaping the operating environment for the JSC “Latvijas Gāze”.In 2020, the JSC “Latvijas Gāze” sold 11 896 GWh of natural gas to customers in Latvia and abroad, with the latter accounting for 28% of the total JSC “Latvijas Gāze” natural gas sales volumes.The Group’s net turnover in 2020 reached 190.5 million EUR, EBITDA amounted to 26.5 million EUR. The Group’s net profit for 2020 was 11.2 million EUR*.The JSC “Latvijas Gāze” in 2020 continued to invest towards improving the effectiveness and efficiency of core business and customer care processes. In total the JSC “Latvijas gāze”...

Continue reading

“Latvijas Gāze” koncerna nerevidētie finanšu rezultāti par 2020. gadu

2020. gads ir bijis izaicinājumiem pilns gan pasaulei kopumā, gan enerģētikas nozarei. Salīdzinoši mērenas gaisa temperatūras, stingrie ierobežojumi saistībā ar koronavīrusa izplatību un zemais dabasgāzes cenu līmenis bija noteicošie faktori, kas veidoja AS “Latvijas Gāze” darbības vidi.2020. gadā AS “Latvijas Gāze” klientiem Latvijā un ārvalstīs pārdeva 11 896 GWh dabasgāzes. Ārpus Latvijas pārdošanas apjomi sasniedza 28% no AS “Latvijas Gāze” kopējiem dabasgāzes pārdošanas apjomiem.Koncerna neto apgrozījums 2020. gadā sasniedza 190.5 miljonus EUR, EBITDA – 26.5 miljonus EUR.  Koncerna neto peļņa 2020. gadā bija 11.2 miljonus EUR.AS “Latvijas Gāze” turpināja veikt virkni investīciju efektīvākai kvalitatīvu produktu un pakalpojumu sniegšanai klientiem. Kopumā 2020. gadā AS “Latvijas Gāze” IT investīciju projektiem atvēlēja aptuveni...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.